Pottegård, Anton http://orcid.org/0000-0001-9314-5679
Pedersen, Sidsel Arnspang http://orcid.org/0000-0001-7457-9092
Schmidt, Sigrun Alba Johannesdottir
Lee, Chaw-Ning
Hsu, Chao-Kai
Liao, Tzu-Chi
Shao, Shih-Chieh
Lai, Edward Chia-Cheng
Article History
Received: 12 June 2019
Accepted: 8 October 2019
First Online: 1 November 2019
Competing interests
: Anton Pottegård reports having received funding from LEO Pharma to the institution where he is employed, for unrelated projects. The remaining authors declare no competing interests.
: The study was approved by the Institutional Review Board of National Cheng-Kung University Hospital (B-ER-107-378) that also waived the requirement for informed consent by the participants. We performed the study in accordance with the Declaration of Helsinki.
: This study was supported in part by a grant from Taiwan’s Ministry of Science and Technology (107-2320-B-006-070-MY3). The funder had no role in the design, conduct, or data interpretation of the study.
: Not applicable.
: The data that support the findings of this study are available from Taiwan’s National Health Insurance Research Database (NHIRD). Restrictions apply to the availability of these data, which were used under license for this study.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).